CONFIRMATION that Chinese authorities will continue to open up the local market for a shared future has been welcomed by Complementary Medicines Australia CEO Carl Gibson.
Gibson, who is currently attending the China International Import Expo, hailed an announcement saying China would expand its free trade zones and provide more certainty around e-commerce rules for imported products.
"This is very welcome news for the Australian complementary medicines industry," he said, noting that Australia was on the cusp of overtaking the USA as the top supplier of complementary medicines imported into China.
"Our products are well recognised as a premium brand in the complementary medicines sector thanks to our strict quality and safety manufacturing standards and Australia's clean and green reputation," Gibson said.
Other key indicators include the Healthy China 2030 vision which makes health a priority for the country and a central consideration in all policy making.
"Supported by strengthened e-commerce rules, this provides huge potential for Australian complementary medicines," he said.
Gibson noted that with more than 60% of locally based companies in the sector engaged in export and increasing recognition for Australian brands abroad, "ours is an industry with huge potential to become a long-term success story".
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Nov 18
